Investor Alert

London Markets Open in:

Company Close Updates Archives | Email alerts

Dec. 10, 2020, 5:06 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 1.12% to $1.32 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.54% to 12,405.81 and the Dow Jones Industrial Average DJIA falling 0.23% to 29,999.26. This was the stock's second consecutive day of losses. Corbus Pharmaceuticals Holdings Inc. closed $8.46 below its 52-week high ($9.78), which the company reached on August 31st.

The stock underperformed when compared to some of its competitors Thursday, as Fate Therapeutics Inc. FATE rose 11.84% to $96.85, Vanda Pharmaceuticals Inc. VNDA rose 0.41% to $13.44, and Viking Therapeutics Inc. VKTX rose 2.51% to $6.13. Trading volume (3.0 M) remained 1.6 million below its 50-day average volume of 4.6 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.